Tavo Biotherapeutics, a leading innovator in the ophthalmology industry, today announced the appointment of Lukas Scheibler, Ph.D. as Chief Research and Development Officer, and Graham Cooper as Chief ...

Belite Bio, Inc. (NASDAQ: BLTE), a clinical-stage biopharmaceutical drug development company focused on advancing novel ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness ...

Dogs experiencing vision loss may begin bumping into objects, hesitating on stairs, or struggling with uneven surfaces. You ...

Attendance Allowance could help people who are severely short-sighted or have eye conditions including cataract, glaucoma or ...

Structural biomarkers identifiable on OCT-A can provide details regarding the development and progression of structural changes in MacTel 2.

Private equity (PE) firms have increased their ownership stake across health care sectors in the US. PE’s focus on short-term profitability may decrease the provision of unprofitable services, ...

The retina, as part of the central nervous system, may reflect early signs of brain disorders like schizophrenia.

A compelling naturopathic case study by Dr. Eric Dorninger reveals how endotoxin exposure from kitty litter led to CIRS and ...

The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for aflibercept injection 8mg for the treatment of macular edema following ...

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has issued a complete response letter ...